Sort   by:  
 Page size 
ProteomicsPROTEOMIC ANALYSIS OF EARLY DIABETIC RETINOPATHY REVEALS MEDIATORS OF NEURODEGENERATIVE BRAIN DISEASES
The aim of the present study was to identify early changes in diabetic retinas using an unbiased proteomics approach. Proteomic profiles of control retinas were compared to diabetic retinas obtained from patients known to have no classic vascular lesions that clinically define diabetic retinas. The ...
ORGANISM(S): Homo sapiens (Human) 
2022-03-02 | PXD008989 | Pride
Human retina Diabetes 
GenomicsDCC_R27_WGS_Runs.1 - samples
Raw lane level fastq files from Whole genome sequencing in support of ICGC PRAD-CA Variant calls
EGAD00001003909 | EGA
GenomicsDCC_R27_WGS_Runs.4 - samples
Raw lane level fastq files from Whole genome sequencing in support of ICGC PRAD-CA Variant calls
EGAD00001003975 | EGA
GenomicsDCC_R27_WGS_Runs.3 - samples
Raw lane level fastq files from Whole genome sequencing in support of ICGC PRAD-CA Variant calls
EGAD00001003957 | EGA
UnknownVitamin D Levels as an Important Predictor for Type 2 Diabetes Mellitus and Weight Regain Post-Sleeve Gastrectomy.
Not available
S-EPMC9143791 | biostudies-literature
UnknownThe Feasibility of Smartwatch Micro-Ecological Momentary Assessment for Tracking Eating Patterns of Malaysian Children and Adolescents in the South-East Asian Community Observatory Child Health Update 2020: Cross-Sectional Study.
Not available
S-EPMC12924041 | biostudies-literature
UnknownHuman BioMolecular Atlas Program (HuBMAP): 3D Human Reference Atlas construction and usage.
Not available
S-EPMC11978508 | biostudies-literature
UnknownBET inhibitor resistance emerges from leukaemia stem cells.
Not available
S-EPMC6069604 | biostudies-literature
GenomicsChIP of BET proteins in iBET resistance [ChIP-seq]
Bromodomain and Extra Terminal protein (BET) inhibitors are first-in-class targeted therapies that deliver a new therapeutic paradigm by directly targeting epigenetic readers1,2. Early clinical trials have shown significant promise especially in acute myeloid leukaemia (AML)3; therefore the evaluati...
ORGANISM(S): Mus musculus 
2015-09-15 | E-GEOD-63682 | biostudies-arrayexpress
TranscriptomicsGenome wide expression analysis of BET inhibitor resistance [RNA-seq]
Bromodomain and Extra Terminal protein (BET) inhibitors are first-in-class targeted therapies that deliver a new therapeutic paradigm by directly targeting epigenetic readers1,2. Early clinical trials have shown significant promise especially in acute myeloid leukaemia (AML)3; therefore the evaluati...
ORGANISM(S): Mus musculus 
2015-09-15 | E-GEOD-63681 | biostudies-arrayexpress
Sort   by:  
 Page size